These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28805783)

  • 1. [Effect of the Cytoflavin on the distal polyneuropathy severity in patients with diabetic foot syndrome with arteries mediacalcinosis].
    Skripko VD; Kovalenko AL; Zaplutanov VA
    Khirurgiia (Mosk); 2017; (8):75-78. PubMed ID: 28805783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries].
    Mikhaloĭko IIa; Sabadosh RV; Kovalenko AL; Skripko VD
    Khirurgiia (Mosk); 2014; (12):36-40. PubMed ID: 25589316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [EFFICACY OF CYTOFLAVIN IN COMPLEX TREATMENT OF DIABETIC FOOT SYNDROME].
    Skrypko V; Kovalenko A; Zaplutanov V; Kharitonova T; Myhaloyko I
    Georgian Med News; 2017 Apr; (265):14-19. PubMed ID: 28574379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome].
    Asadullaev MM; Saidvaliev FS; Shermukhamedova FK; Rizvonov ZhK; Vakhabova NM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10):24-7. PubMed ID: 23250593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of cytoflavin in the treatment of vertebrobasilar insufficiency].
    Beĭn BN; Dravert NE
    Eksp Klin Farmakol; 2010 Apr; 73(4):8-10. PubMed ID: 20486551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [THE PHARMACOTHERAPEUTIC EFFICIENCY OF CYTOFLAVIN IN PATIENTS WITH DIABETIC FOOT SYNDROME: IMMEDIATE AND LONG-TERM RESULTS].
    Markevich PS; Markevich LB; Plekhanov AN; Kovalenko AL
    Klin Med (Mosk); 2015; 93(6):67-72. PubMed ID: 26495531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of cytoflavin in patients with hypertonic encephalopathy and constitutional venous insufficiency].
    Belova LA; Mashin VV; Kolotik-Kameneva OIu; Belova NV; Byrina AV; Evstigneeva AIu; Abramova VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):21-6. PubMed ID: 23096033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin].
    Madzhidova EN; Usmanova DD; Baĭtursunova ZhM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):57-62. PubMed ID: 23235414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection].
    Isakov VA; Kovalenko AL; Turkin VV; Makarov VI
    Antibiot Khimioter; 2010; 55(1-2):36-41. PubMed ID: 20583556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of the energy-modifier cytoflavin in the treatment of patients with hypertensive encephalopathy].
    Belova LA; Kolotik-Kameneva OIu; Mashin VV; Saprygina LV; Mashin EV
    Ter Arkh; 2014; 86(9):65-70. PubMed ID: 25518508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytoflavin rationale for the use in treatment of patients with postsurgical hypothyroidism].
    Skripkо VD; Pasko AJ; Kovalenko AL; Zaplutanov VA
    Khirurgiia (Mosk); 2016; (7):53-57. PubMed ID: 27459489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficiency of cytoflavin in the treatment of somatoform disorders].
    Chutko LS; Surushkina SY; Yakovenko EA; Anisimova TI; Prokopenko SM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(1):21-24. PubMed ID: 28252599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [EFFECTIVENESS OF CYTOFLAVIN FOR THE CORRECTION OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS].
    Gatskikh IV; Veselova OF; Brikman IN; Shalda TP; Varygina EL; Kuznetsov MN; Shul'min AV; Petrova MM
    Eksp Klin Farmakol; 2015; 78(11):21-5. PubMed ID: 27017701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study cytoflavin dose-dependent effect in the treatment of acute ischemic stroke].
    Sazonov IE; Kudinov AA; Fedotova EP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):64-67. PubMed ID: 28374695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dynamics of cognitive disorders in patients with type 2 diabetes mellitus under effect of metabolic therapy].
    Gatckikh IV; Petrova MM; Shalda TP; Varygina EL; Kuznetsov MN; Narkevich AN
    Klin Med (Mosk); 2016; 94(7):533-9. PubMed ID: 30289219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effectiveness of cytoflavin inclusion in intensive care of patients with combined traumatic brain injury].
    Lebedeva EA; Kurtasov AA; Belousova ME; Nemkova ZA; Kaminskiĭ MIu; Popov RV; Trofimovich SL
    Eksp Klin Farmakol; 2014; 77(4):42-4. PubMed ID: 25076759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of cytoflavin on the clinical and autonomic-psychological manifestations of hypertensive disease].
    Belova LA; Mashin VV; Kolotik-Kameneva OY; Belova NV
    Ter Arkh; 2016; 88(5):55-61. PubMed ID: 27239928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience of cytoflavin administration for treating acute carbon monoxide poisoning].
    Zobnin IuV; Petrova AG; Provado IP; Afanas'ev VV
    Eksp Klin Farmakol; 2011; 74(10):39-42. PubMed ID: 22238986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of the complex drug cytoflavin in the treatment of consequences of mild brain injury].
    Skoromets AA; Pugacheva EL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3):31-6. PubMed ID: 20517223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Features of psychopharmacotherapeutic correction of alcohol dependence in the elderly].
    Belov VG; Parfenov IuA; Zaplutanov VA
    Adv Gerontol; 2013; 26(4):702-6. PubMed ID: 24738263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.